Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 721,789 | 637,592 | 626,336 | 605,446 | 605,303 |
| Cost of Goods | 299,183 | 258,250 | 266,746 | 274,297 | 260,353 |
| Gross Profit | 422,606 | 379,342 | 359,590 | 331,149 | 344,950 |
| Operating Expenses | 250,933 | 186,344 | 216,011 | 215,815 | 205,501 |
| Operating Income | 171,856 | 193,248 | 144,325 | 115,631 | 139,802 |
| Interest Expense | 8,110 | 9,495 | 7,692 | 7,393 | 7,090 |
| Other Income | 208 | 69 | 140 | 268 | 86 |
| Pre-tax Income | 163,954 | 183,822 | 136,773 | 108,506 | 132,798 |
| Income Tax | 17,633 | 34,826 | 24,917 | 17,962 | 23,960 |
| Net Income Continuous | 146,321 | 148,996 | 111,856 | 90,544 | 108,838 |
| Minority Interests | 102 | 56 | 29 | 48 | 1 |
| Net Income | $146,219 | $148,940 | $111,827 | $90,496 | $108,837 |
| EPS Basic Total Ops | 1.71 | 1.75 | 1.31 | 1.06 | 1.26 |
| EPS Basic Continuous Ops | 1.72 | 1.75 | 1.31 | 1.06 | 1.26 |
| EPS Diluted Total Ops | 1.69 | 1.72 | 1.29 | 1.05 | 1.24 |
| EPS Diluted Continuous Ops | 1.69 | 1.72 | 1.29 | 1.04 | 1.24 |
| EBITDA(a) | $196,507 | $216,830 | $167,529 | $138,220 | $162,248 |